Surgalign Holdings, Inc. Common Stock
SRGA
SRGA was delisted on the 30th of June, 2023.
0 hedge funds and large institutions have $0 invested in Surgalign Holdings, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 4 closing their positions.
100% less funds holding
Funds holding: 4 → 0 (-4)
100% less capital invested
Capital invested by funds: $1.72K → $0 (-$1.72K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$1.25K |
| 2 |
BBA
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
|
-$245 |
| 3 |
SAM
Silvercrest Asset Management
New York
|
-$227 |
| 4 |
WWP
WR Wealth Planners
Columbia,
Missouri
|
-$1 |
SRGA Hedge Fund Activity: Q4 2023 in Review
0 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q4 2023, worth a combined $0 — down 100% from $1.72K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of SRGA and 0 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Raymond James Financial Services Advisors, exiting entirely with an estimated $1.25K sold.
- 0 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q4 2023, down from 4 in Q3 2023.
- Funds reported $0 of Surgalign Holdings, Inc. Common Stock stock for Q4 2023, down 100% quarter-over-quarter.
- 0 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q4 2023 and 4 closed out, a net change of -4 holders.
- The largest Surgalign Holdings, Inc. Common Stock seller in Q4 2023 was Raymond James Financial Services Advisors, an estimated $1.25K sold.
Based on aggregated 13F filings for Q4 2023.